Nano-X Imaging ended June 30, 2026, with $31.023 million in cash and expanded its U.S. and Latin American presence through distribution, Nanox.ARC and Nanox Imaging Network activity. The company intends to keep raising funds from various sources, a stated step to strengthen its Balance Sheet and support activities.

Key Highlights

  • An additional Nanox.ARC capital-equipment agreement placed a system at a Florida orthopedic center within an integrated delivery network.
  • The first Nanox Imaging Network site launched with first patient scans.
  • Nanox.AI added Vertec Scientific as an exclusive reseller and launched five new pilot programs.

Nano-X Imaging Ltd. (NASDAQ: NNOX) reported an additional U.S. distribution agreement and a Costa Rica distribution agreement supporting continued expansion across Latin America while holding $31.023 million in cash at June 30, 2026. The balance stood at $49.151 million on December 31, 2025. The second-quarter Business update also covered Nanox.ARC sales, the first Nanox Imaging Network site and continued Nanox.AI commercial and clinical momentum.

Nanox.ARC Extends U.S. Reach

An additional U.S. distribution partner agreement expanded Nanox’s presence in the country. The company also added a Nanox.ARC capital-equipment agreement that placed a system at an internationally recognized orthopedic center in Florida, which is part of an integrated delivery network. The first Nanox Imaging Network site launched, with initial patient scans.

Nanox.AI Adds Commercial Momentum

The company also furthered a broad restructuring of its Korea operations, including its at-the-market program.

Balance Sheet and Funding

Nanox reported total Assets of $91.185 million at June 30, 2026, compared with $162.165 million at December 31, 2025. Total liabilities were $18.717 million at June 30, 2026, versus $22.433 million at December 31, 2025.